Table 2 Immunosuppressive therapies across the immunocompromised traveller cohort

Antimetabolite

22

Azathioprine

8

Hydroxycarbamide

3

Leflunomide

1

Mercaptopurine

1

Methotrexate

9

TNF Inhibitor

7

Adalimumab

5

Etanercept

2

Steroids

5

Anti-CD20

4

Rituximab

4

Mycophenolate mofetil

4

Calcineurin Inhibitor

4

Sirolimus

1

Tacrolimus

3

α4-integrin inhibitor

3

Natalizumab

2

Vedolizumab

1

Interferon therapy

2

Peginterferon alfa-2a

1

Interferon beta-1α

1

BCR-ABL tyrosine kinase inhibitor

1

Nilotinib

1

Sphingosine 1-phosphate receptor modulator

1

Anti-IL6

1

Tocilizumab

1

CD30 Targeted Agent

1

Brentuximab

1

Co-stimulation modulator

1

Abatacept

1

IL-12, IL-23 Pathway Inhibitor

1

Ustekinumab

1

Total

57